Search Filters

Search Results

Found 2 results

510(k) Data Aggregation

    K Number
    K142806
    Device Name
    DualCap
    Date Cleared
    2015-05-22

    (235 days)

    Product Code
    Regulation Number
    880.5440
    Reference & Predicate Devices
    Predicate For
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    When left in place for 30 seconds the Light Blue DualCap® disinfects needleless luer access valves and the Dark Blue DualCap® disinfects the IV administration line male luer connections; the caps provide a physical barrier to contamination up to 7 days, under normal conditions if not removed.

    Device Description

    The DualCap® Disinfectant Cap is designed to fit securely on Luer access valves and IV administration line male Luer connections. The cap contains 70% isopropyl alcohol. The Subject device is not made with natural rubber latex, is non-pyrogenic, non-preservative and is not made with DEHP. The product consists of a Light Blue DualCap® for use on Luer access valves and a Dark Blue DualCap® for use on IV administration line male Luer connections. The Light Blue DualCaps® and Dark Blue DualCaps® are available in a number of packaging combinations such as two Light Blue DualCaps®, a Light Blue DualCap® and Dark Blue DualCap® combination, and as singles.

    Additionally, DualCap® Disinfectant Caps will be marketed for use as an accessory in procedure kits. When being used in procedural kits, the product will be shipped bulk to the kitting manufacturer.

    AI/ML Overview

    The provided text describes a 510(k) summary for the DualCap® Disinfectant Caps, which is a medical device intended to disinfect needleless luer access valves and IV administration line male luer connections. The document outlines acceptance criteria related to disinfection efficacy and physical barrier integrity, along with the performance data supporting these claims.

    Here's an analysis based on the information provided:

    1. Table of Acceptance Criteria and Reported Device Performance

    Acceptance CriteriaReported Device Performance
    Disinfection Efficacy: ≥ 4-log reduction in specified test organisms (Staphylococcus aureus, Staphylococcus epidermidis, Pseudomonas aeruginosa, Escherichia coli, and Candida albicans) with a 30-second exposure time.In vitro antimicrobial efficacy studies completed on DualCap® Disinfectant Caps under worst-case conditions show a ≥ 4 log reduction in each test organism (Staphylococcus aureus, Staphylococcus epidermidis, Pseudomonas aeruginosa, Escherichia coli, and Candida albicans). This supports the 30-second disinfection time.
    Physical Barrier to Contamination: Maintain an air-tight seal for up to 7 days, preventing contamination.Testing was performed to show that there was an air-tight seal between the LAV and light blue DualCap® Disinfecting Cap and an air-tight seal between the male luer connector and the dark blue DualCap® Disinfecting Cap after 7 days. This supports the 7-day use-of-life claim.
    Material Biocompatibility: Conformance to FDA Blue Book Memorandum #G95-1 and ISO 10993.Biocompatibility testing (Cytotoxicity, Sensitization, Irritation or Intracutaneous Reactivity, Systemic Toxicity, Hemocompatibility) was conducted and the device met the requirements.
    Luer Compatibility & Integrity: Conformance to ISO 594 (various clauses: gauging, liquid leakage under pressure, separation force, ease of assembly, resistance to overriding, securement threads).All applicable Physical tests (ISO 594-1 and ISO 594-2) were completed and the DualCap® Disinfectant Caps passed all tests. This includes ensuring compatibility with standard male Luer IV connectors, accessible injection valves, and demonstrating the securement threads.
    Prevention of Disinfectant Entry into Fluid Path: Ensure disinfectant does not enter the intraluminal space of male luers.Testing was completed to demonstrate that the DualCap® Disinfectant Caps for Male Luers did not allow disinfectant to enter into the fluid path of the male luers. This was verified for the Dark Blue component.

    2. Sample Size Used for the Test Set and Data Provenance

    The document does not specify the exact sample sizes for the "test set" in the traditional sense of a clinical trial. The performance data is primarily based on in vitro studies and bench testing.

    • In vitro antimicrobial efficacy studies: "worst case conditions" were used, but no specific number of samples (e.g., number of caps tested, number of replicates per organism) or test runs are detailed.
    • Air-tight seal study: No specific number of caps or connections tested is provided.
    • Biocompatibility testing: Standard battery of tests was performed in accordance with ISO 10993. The number of samples for each test (e.g., cytotoxicity, sensitization) is not specified.
    • Physical tests (ISO 594): No specific number of caps or connections tested is provided.
    • Prevention of disinfectant entry: Not specified.

    Data Provenance: All studies described appear to be in vitro laboratory studies or bench testing. The document does not indicate any human clinical trials, patient data, or geographical origin of data (e.g., country).

    3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications

    Not applicable. The ground truth for this device's performance is established by the results of standardized laboratory tests and engineering benchmarks (e.g., ISO 594, microbial log reduction). It does not involve human interpretation of images or clinical data that would require experts to establish a "ground truth."

    4. Adjudication Method for the Test Set

    Not applicable. As the ground truth is established by objective laboratory measurements and standardized test results rather than expert consensus on subjective data, an adjudication method is not relevant.

    5. Multi Reader Multi Case (MRMC) Comparative Effectiveness Study

    No. No MRMC comparative effectiveness study was conducted. This type of study is typically used for diagnostic devices where human readers interpret medical images or data, and the effect of AI on their performance is measured. The DualCap® Disinfectant Caps are a physical device with a disinfection and barrier function, not a diagnostic AI tool.

    6. Standalone (Algorithm Only) Performance Study

    Yes, in essence. The performance studies described (microbiological efficacy, physical tests, biocompatibility) represent the "standalone" performance of the device itself (the cap with its integrated alcohol) without human intervention influencing the core disinfection or barrier function during the test. While users apply the cap, the efficacy tests are assessing the inherent properties of the device system.

    7. Type of Ground Truth Used

    The ground truth used is primarily objective laboratory measurements and international standard compliance:

    • Microbiological performance: Measured log reduction of specific microorganisms.
    • Physical performance: Conformance to engineering standards (ISO 594) through metrics like leakage, separation force, and thread compatibility.
    • Biocompatibility: Results of standardized in vitro and in vivo biological tests as per ISO 10993.
    • Barrier function: Demonstrated air-tight seal.
    • Prevention of fluid path contamination: Direct measurement of alcohol presence in the fluid path.

    8. Sample Size for the Training Set

    Not applicable. This device is a physical product, not an AI/ML algorithm that requires a "training set" of data for development. The design and validation are based on engineering principles, material science, and microbiological efficacy, not machine learning.

    9. How the Ground Truth for the Training Set Was Established

    Not applicable. (See point 8)

    Ask a Question

    Ask a specific question about this device

    K Number
    K142399
    Date Cleared
    2014-11-19

    (84 days)

    Product Code
    Regulation Number
    880.5440
    Reference & Predicate Devices
    Predicate For
    N/A
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    When left in place for five (5) minutes, the Dark Blue DualCap disinfects male luer connectors; thereafter the caps provide a physical barrier to contamination up to ninety-six (96) hours under normal conditions if not removed.

    Device Description

    The Dark Blue DualCap" is designed to Internet on all ISO standard mater and man and newides effective disintection of the male luer fromector after five minutes of applicat sterite. This device is not made with natural rubber latex, is non-pyrogenic, preservative free and is not made with DEHP, Additionally Datk Blue DualCap® will be marketed for use as an accessory in procedure kits. When being used in procedural kits, the product will be shipped bulk sterite to the kitting manufacturer for incorporation into the procedure Kits,

    AI/ML Overview

    The provided document describes the Catheter Connections' Dark Blue DualCap® for Male Luers (K142399), a device intended to disinfect and protect male luer connectors. Here's an analysis of the acceptance criteria and supporting studies based on the provided text, using the requested format:

    Acceptance Criteria and Device Performance

    Acceptance Criteria CategorySpecific CriteriaReported Device Performance
    Intended UseDisinfect male luer connectors within five (5) minutes after application.The Dark Blue DualCap disinfected male luer connectors within five (5) minutes.
    Act as a physical barrier to contamination up to ninety-six (96) hours under normal conditions if not removed.The Dark Blue DualCap provided a physical barrier to contamination up to ninety-six (96) hours under normal conditions if not removed.
    BiocompatibilityCompliant with FDA Blue Book Memorandum #G95-1 "Use of International Standard ISO 10993, "Biological Evaluation of Medical Devices Part 1 Evaluation and Testing, "May 1, 1995. This includes tests for Cytotoxicity, Sensitization, Irritation or Intracutaneous Reactivity, Systemic Toxicity, Hemocompatibility, and Pyrogen.The biocompatibility evaluation for the dark blue cap was conducted in accordance with the specified standard and included all listed tests. The submission device and predicate devices are stated to be identical in this regard. (Implied successful completion).
    Microbiological EfficacyAchieve a specific log reduction in antimicrobial activity against selected organisms (Staphylococcus aureus, Pseudomonas aeruginosa, Streptococcus pyogenes, MRSA, VRE, Candida albicans, Candida krusei) using ASTM E 2315-03, 2008.Time Kill Studies showed a ≥ 4 log reduction in all cases for various microorganisms, including Staphylococcus aureus, Pseudomonas aeruginosa, Streptococcus pyogenes, antibiotic-resistant bacteria (MRSA, VRE), and yeasts (Candida albicans, Candida krusei).
    Achieve a specific log reduction in antimicrobial efficacy on the DualCap for Male Luers under worst-case conditions against Staphylococcus aureus, Staphylococcus epidermidis, Pseudomonas aeruginosa, and Escherichia coli.Additional in vitro antimicrobial efficacy studies completed under worst-case conditions showed a ≥ 4 log reduction for each test organism (Staphylococcus aureus, Staphylococcus epidermidis, Pseudomonas aeruginosa, and Escherichia coli).
    Physical CompatibilityCompatible with typical male luer devices adhering to ISO594-1 and ISO 594-2 standards.Testing using ISO594-1 and ISO 594-2 was completed for the Dark Blue DualCap® for Male Luers, and the device "passed all tests."
    Disinfectant ContainmentThe device should not allow disinfectant to enter into the fluid path of the male luers."Testing was also completed to demonstrate that the Dark Blue DualCap® for Male Luers did not allow disinfectant to enter into the fluid path of the male luers." (Implied successful demonstration).

    Study Details

    The document refers to a 510(k) Premarket Notification Submission (K142399) for the Catheter Connections' Dark Blue DualCap® for Male Luers. The submission device is explicitly stated to be physically identical to the predicate device (DualCap™ for Male Luers, K123967) in terms of "intended use, design, materials, operation, function, and sterilization method." Therefore, the performance data provided supports the substantial equivalence by demonstrating the new device performs identically to the predicate.

    1. Sample size used for the test set and the data provenance:

      • Sample Size: The document does not specify exact sample sizes for each test in the performance data section. It mentions "Time Kill Studies" and "Additional in vitro antimicrobial efficacy studies" without giving the number of samples per test. For physical testing, it states "Applicable testing using ISO594-1 and ISO 594-2 was completed" and "passed all tests," again without specific sample counts.
      • Data Provenance: Not explicitly stated, but the testing appears to be laboratory-based ("in vitro antimicrobial efficacy studies") rather than from human clinical studies. The origin country of the data is not mentioned, but the submission is to the U.S. FDA. The studies are prospective in nature, designed to assess specific performance characteristics.
    2. Number of experts used to establish the ground truth for the test set and the qualifications of those experts:

      • This type of information (experts establishing ground truth) is typically relevant for studies involving human interpretation (e.g., image analysis, diagnosis) or clinical endpoints where expert consensus is needed. For the performance data presented (biocompatibility, microbiological efficacy, physical compatibility, disinfectant containment), the "ground truth" is established by adherence to recognized standards (e.g., ISO, ASTM, FDA guidelines) and objective laboratory measurements, rather than expert consensus on a test set. Therefore, this information is not applicable in the context of the provided performance data.
    3. Adjudication method for the test set:

      • Adjudication methods (e.g., 2+1, 3+1) are typically used in clinical trials or studies where multiple readers or experts assess cases, and their disagreements need resolution. Since the described tests are objective laboratory measurements against defined standards, an adjudication method is not applicable.
    4. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:

      • No, an MRMC comparative effectiveness study was not done. This device is not an AI-powered diagnostic tool or one that involves human readers for interpretation.
    5. If a standalone (i.e. algorithm only without human-in-the loop performance) was done:

      • This question is typically relevant for software or AI medical devices. The Dark Blue DualCap is a physical device (disinfectant cap). Therefore, the concept of "standalone algorithm performance" is not applicable. The performance tests assessed the device's inherent physical and functional properties.
    6. The type of ground truth used:

      • Biocompatibility: Adherence to established FDA guidelines and international standards (ISO 10993) for biological evaluation.
      • Microbiological Efficacy: Objective measurement of log reduction against specified microorganisms, following industry standard protocols (ASTM E 2315-03, 2008). The ground truth is the quantitative antimicrobial activity observed in the laboratory.
      • Physical Compatibility: Compliance with international standards for luer connectors (ISO594-1 and ISO 594-2). Ground truth is successful meeting of the physical specifications.
      • Disinfectant Containment: Objective measurement or observation of the absence of disinfectant ingress into the fluid path.
    7. The sample size for the training set:

      • This pertains to machine learning models (AI). As this is a physical medical device, there is no "training set" in the context of an algorithm.
    8. How the ground truth for the training set was established:

      • As there is no training set for an algorithm, this question is not applicable to the device described.
    Ask a Question

    Ask a specific question about this device

    Page 1 of 1